MD Anderson Cancer Center Director, Investigational New Drug Office (IND) in Houston, Texas
The Director, Investigational New Drug Office, provides strategic planning and administrative leadership to ensure institutional compliance with federal agencies in the development and conduct of investigator-initiated studies for which MD Anderson serves as the study sponsor. The IND Office is part of the Office of Clinical Research Administration.
Five years of leadership experience in a clinical research operation;
Managing the IND component of an academic medical center
Human Subjects Protection program
Representing an organization at national scientific meetings and conferences
Bachelor's Level Degree
EQUAL EMPLOYMENT OPPORTUNITY
Diversity and inclusion at MD Anderson are not just important; they are essential. Workforce diversity is one of its greatest strengths and keys to success in our mission to cure cancer. We take an expansive view of diversity, considering differences in race, ethnicity, sexual orientation, gender and religious beliefs, as well as communication styles, thought, skill and ambition.
It is the policy of MD Anderson Cancer Center to provide equal employment opportunity without regard to race, color, religion, age, national origin, sex, gender, sexual orientation, gender identity/expression, disability, protected veteran status, genetic information, or any other basis protected by institutional policy or by federal, state or local laws unless such distinction is required by law.
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. As part of its efforts to achieve these goals of a tobacco-free hiring process, if you are offered a position at MD Anderson Cancer Center, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws.
Employee Status: Regular
Minimum Salary: US Dollar (USD) 0
Midpoint Salary: US Dollar (USD) 0
Maximum Salary : US Dollar (USD) 0